PDL BIOPHARMA INC PDLI (NASDAQ)

(NEW YORK)Five companies in the health care sector were added to the Russell 1000 in this year's reconstitution of the large stock index, while one stock in the sector was removed.READ MORE

(REDWOOD CITY, Calif.)PDL BioPharma Inc. said director and interim Chief Executive L. Patrick Gage resigned due to differences among the board about prioritizing company goals.READ MORE

(NEW YORK)As growth slows in shares of large-cap biotechs and economic woes weigh on the broader markets, investors can find dramatic growth opportunities in many small and midcap biotechs w...READ MORE

(REDWOOD CITY, Calif.)Shares of PDL BioPharma Inc. fell Friday, after the company said its first-quarter loss widened on discontinued operations related to the sale of several key drug assets.READ MORE

(NEW YORK) PDL BioPharma shares are surging after the company said it will split up, spinning off its biotechnology assets into a new company and paying a $4.25 dividend to shareholders. Th...READ MORE

(NEW YORK) Stocks that are moving substantially or trading heavily Friday on the New York Stock Exchange and Nasdaq Stock Market: NYSE General Electric Co., down $4.22 at $32.53 After pos...READ MORE

(NEW YORK) Shares of biotechnology companies are trading lower Friday, after Genentech reported lower-than-expected quarterly revenue due to disappointing sales of cancer drug Avastin. Thoma...READ MORE